Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-alanine is a non-essential alpha-amino acid that serves as a fundamental building block for protein biosynthesis and plays a pivotal role in the glucose-alanine cycle (PubChem CID 5950). In this cycle, alanine is synthesized in muscle tissue from pyruvate and transported to the liver, where it is converted back into glucose via gluconeogenesis, providing an energy source during fasting or intense exercise (StatPearls, "Biochemistry, Alanine"). While L-alanine itself is not a therapeutic target in the traditional sense of a protein receptor or enzyme, it is a critical metabolite whose levels are regulated by enzymes like alanine aminotransferase (ALT) (UniProt P00505). Clinically, L-alanine is used in parenteral nutrition to maintain nitrogen balance and is studied for its role in metabolic disorders such as hyperalaninemia and diabetes (HMDB0000161). It is also utilized as a dietary supplement and in the formulation of various pharmaceutical products to support metabolic health.
Acts as a substrate for gluconeogenesis and protein synthesis; serves as a nitrogen carrier between muscle and liver (StatPearls).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-alanine (Ala) (Ala).